Tanshinone IIA inhibited the expression and release of IL-6 and TNF-α in neutrophils and promoted the apoptosis of neutrophils, suggesting its potential in improving RA by targeting neutrophils. The gene discussed is IL6; the disease is rheumatoid arthritis.